Lois Rajcan, PhD, RN, has more than 38 years of experience as a registered nurse across diverse clinical settings, including 10 years specializing in vascular access as a clinical manager. Her commitment to safe, patient-centered vascular access practice has shaped both her scholarly work and her contributions to nursing education. She has conducted research examining patients’ trust in nurses and their perceptions of nursing care quality when nurses access implanted vascular access ports. Active in nursing education since 2011, she also developed an undergraduate vascular access and infusion therapy course designed to strengthen foundational competence and promote evidence-based practice among emerging nurses.

Marlene Steinheiser, PhD, RN, CRNI®, Chief Clinical Officer at INS, is responsible for supporting the vision and mission of the organization nationally and globally, which includes strategic planning and development of new programs, research, and education. Additionally, she provides leadership and oversight for the Editor-in-Chief of the Journal of Infusion Nursing and the Editor in Chief of the Infusion Therapy Standards of Practice, ensuring alignment with the organization’s strategic vision and publication standards.

Dr Steinheiser has been a CRNI since 1991 and has 40 years of nursing experience. Her background includes work in diverse clinical settings, faculty roles in both pre-licensure and post-licensure nursing education, and service as a nurse practice consultant for a state nursing regulatory board. Her passion for infusion therapy and vascular access has been integrated into each of her varied career roles.

Dr Steinheiser holds a PhD from the University of Arizona, a master’s degree and a Bachelor of Science in nursing from the University of Akron, and a nursing diploma from Cleveland Metropolitan General Hospital School of Nursing. She conducts research on infusion therapy, vascular access, and compassion fatigue in nursing, with a particular interest in mixed methods research and qualitative data analysis. She also presents nationally and internationally on infusion therapy and vascular access topics.

Chris Cavanaugh, MSN, RN, CRNI®, VA-BC, has been an RN for more than 25 years and has worked in many health care settings, always with a focus on vascular access and infusion therapy.  She has been involved with both the Association for Vascular Access (AVA) and Infusion Nurses Society (INS) since 1995 and has served as a board member, committee chair, committee member, and speaker for both organizations. Ms Cavanaugh was a co-author for the AVA CPG Guidelines and a chapter in the latest Vessel Health and Preservation book. Her master's degree capstone project investigated the disparities and stresses on the health care system caused by patients with a history of substance use. Ms Cavanaugh interviewed and collected data from 100 hospitals across the United States and has been an advocate for treatment with dignity ever since.

MiKaela M. Olsen, DNP, APRN-CNS, AOCNS®, FAAN, serves as the Clinical Program Director for Oncology at Johns Hopkins Hospital and the Johns Hopkins Health System. In this role, she partners with oncology nurse leaders, physician leaders, and frontline clinical staff to advance best practices and ensure seamless coordination of care across the health system. She also works closely with oncology service line leadership to align core competencies and harmonize standards of care throughout the Johns Hopkins Cancer service line.

Dr Olsen holds academic appointments as Adjunct Faculty at the Johns Hopkins School of Nursing and Faculty Associate at the University of Maryland School of Nursing.

She co-chairs the Johns Hopkins Health System Venous Access Device Committees and the central line-associated bloodstream infection (CLABSI) Reduction Committee. Additionally, she is the lead editor of the Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice, 2nd Edition (2023) and the Safe Handling of Hazardous Drugs, 4th Edition (2024). Dr Olsen is the co-chair of the American Society of Clinical Oncology/Oncology Nursing Society (ASCO ONS) Antineoplastic Administration Standards (2025). Her scholarship includes numerous publications and presentations on the safe handling of hazardous drugs and the occupational risks faced by health care workers, antineoplastic drug administration and side effect management, central vascular access devices, and prevention of infection.

As an instructor and consultant, Dr Olsen has shared her expertise internationally, traveling to Singapore, the UAE, China, Bulgaria, and Japan to strengthen nursing education in oncology and to raise global awareness of hazardous drug exposure risks and safe handling practices.

Blake Shay, PharmD, MS, is the Pharmacy Manager at St. Joseph’s Women’s and Children’s Hospital in Tampa, Florida. He oversees the Department of Pharmacy for both Women’s and Children’s service lines, including pediatric oncology, infusion services, and the St. Joseph’s Hemophilia Treatment Center. Additionally, Dr Shay co-coordinates the Health-System Pharmacy Administration and Leadership (HSPAL) residency program at BayCare.

As a pharmacy innovator, he co-founded EnOPrep, a sealed system designed for the safe crushing and dissolving of hazardous medications at the point of care for oral and enteral administration. He is an active member of American Society of Health System Pharmacists (ASHP) and Florida Society of Health System Pharmacists (FSHP), has published extensively on hazardous drug safety, and consults as a content expert for gene and cell therapy site readiness.

Appointed by the state of Florida to the Rare Disease Advisory Council, Dr Shay advises the Florida Department of Health on improving health outcomes for individuals with rare diseases. He also serves on the Mercer University College of Pharmacy Alumni Board of Directors. His practice interests include gene and cell therapies, specialty pharmacy, facility design, and hazardous drug safety.

Dr Grace (Hui) Xu, PhD, is a Nurse Practitioner at an Emergency Trauma Center in Australia and a Senior Implementation Science Research Fellow at the Queensland University of Technology. As a Clinician-Researcher, Dr Xu is dedicated to the core belief that patients in emergency departments should receive medical treatment without any associated harm.

Her work focuses on advocating and promoting evidence-based practices in patient care, with a particular emphasis on optimizing insertions and preventing complications associated with vascular access devices in emergency settings.

Kristi Reguin-Hartman, DNP, APRN, ACNS-BC, has more than 20 years of experience in acute care nursing, professional development, and advanced practice as a Clinical Nurse Specialist. Her expertise in technology implementation, product management, and clinical education drives her focus on streamlining workflows through data-driven approaches. She started her nursing journey with an ADN from Nassau Community College in Long Island, New York, and has completed her Doctor of Nursing Practice at the University of North Carolina – Wilmington. Dr Reguin-Hartman currently works as a Clinical Transformation Manager for Philips Healthcare in the Hospital Patient Monitoring division and as Clinical Instructor with East Carolina University. She volunteers for the North Carolina Nurses Association and has volunteered for the Academy of Medical-Surgical Nurses (AMSN) since 2012. She is currently in the second year of her 2-year term as AMSN President.

Hayley Sweetser, MSN, APRN, AGCNS-BC, MEDSURG-BC, CPHQ, WTA-C, is a Clinical Nurse Specialist in Newark, Delaware, who provides support to patients and caregivers within an acute medicine service line. She has a strong passion for medical-surgical nursing and has spent her whole nursing career in this specialty. In her current position, Ms Sweetser is working toward reducing overall patient harm events, improving nursing professional practice, standardizing care processes, and fostering a culture of safety through interdisciplinary collaboration. She strives to advance medical-surgical nursing practice by encouraging alignment with evidence-based practice. One of the exciting ways that she gets to communicate best practices is on the Academy of Medical-Surgical Nurses (AMSN’s) Med-Surg Moments podcast.

DJ Shannon, MPH, CIC, VA-BC, AL-CIP, FAPIC, has been involved in infection prevention and infectious diseases for over a decade, with experience spanning research, state public health, academics, and acute care hospitals. With a background in human biology and epidemiology, his focus is on the intersection of antimicrobial resistance, device-associated infections, and infection prevention. Mr Shannon is the 2025 Immediate Past President of Association for Professionals in Infection Control and Epidemiology (APIC) Indiana. He was a clinical reviewer for the 2021 INS Infusion Therapy Standards of Practice and a co-author of the Association for Vascular Access (AVA) Standards of Care for Peripheral Intravenous Catheters. Most recently, he served as the lead author for the APIC Implementation Guide for Preventing Catheter-Associated Bloodstream Infections (CABSIs) in Adults.